대한의생명과학회지 (Biomedical Science Letters)

  • 제18권3호
  • /
  • Pages.260-267
  • /
  • 2012
  • /
  • 1738-3226(pISSN)
  • /
  • 2288-7415(eISSN)
대한의생명과학회 (The Korean Society for Biomedical Laboratory Sciences)
권호 표지

Comparison of Echocardiogram and Clinical Profile between Metabolically Healthy Obese (MHO) and Non Metabolically Healthy Obese (Non-MHO) Subjects

  • Hong, Seung-Bok (Department of Clinical Laboratory Sciences, Juseong University) ;
  • Shin, Kyung-A (Department of Laboratory Medicine Bundang Jesaeng Hospital) ;
  • Choi, Wan-Soo (Department of Clinical Laboratory Science, Dong-eui Institute of Technology)
  • 투고 : 2012.05.29
  • 심사 : 2012.07.12
  • 발행 : 2012.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Obesity is associated with cardiovascular risk factors, such as dyslipidemia, hypertension and diabetes. However the presence of the obesity related deranged metabolic profiles varies widely among obese individuals. These individuals, known as 'metabolically healthy obese phenotype (MHO)', despite having excessive body fatness, display favorable metabolic profiles characterized by insulin sensitivity, no hypertension, as well as less dyslipidemia, less inflammation. The purpose of this study was to compare cardiac characterization and clinical profile of MHO and Non-MHO (nonmetabolically healthy obese) subjects in men. We measured treadmill exercise capacity (METs) and maximum blood pressure (BP) in 210 subjects through a medical checkup at J General Hospital. Metabolic syndrome was defined according to the modified Adult Treatment Panel III definition criteria. Both MHO and Non-MHO subjects showed statistically significant changes in the left ventricular mass index (P<.001, P<.01, respectively), A-velocity (P<.01, P<.001, respectively), E/A ratio (P<.01, P<.001, respectively), E'-velocity (P<.001, P<.001, respectively), HOMA-IR (P<.01, P<.001, respectively) and maximum systolic BP (P<.01, respectively) compared with the MH-NO (metabolically healthy non obese) subjects. In conclusion, MHO participants were at increased risk of cardiovascular disease and partly metabolic disorder.

키워드

참고문헌

  1. Aguilar-Salinas CA, Garcia EG, Robles L, Riano D, Ruiz-Gomez DG, Garcia-Ulloa AC, Melgarejo MA, Zamora M, Guillen-Pineda LE, Mehta R, Canizales-Quinteros S, Tusie Luna MT, Gomez-Perez FJ. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab. 2008. 93: 4075-4079. https://doi.org/10.1210/jc.2007-2724
  2. Allison TG, Cordeiro MA, Miller TD, Daida H, Squires RW, Gau GT. Prognostic significance of exercise-induced systemic hypertension in healthy subjects. Am J Cardiol. 1999. 83: 371-375. https://doi.org/10.1016/S0002-9149(98)00871-6
  3. Arnlov J, Ingelsson E, Sundstrom J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010. 121: 230-236. https://doi.org/10.1161/CIRCULATIONAHA.109.887521
  4. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998. 47: 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643
  5. Bouchard DR, Langlois MF, Brochu M, Dionne IJ, Baillargeon JP. Metabolically healthy obese women and functional capacity. Metab Syndr Relat Disord. 2011. 9: 225-229. https://doi.org/10.1089/met.2010.0101
  6. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, Poehlman ET. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab. 2001. 86: 1020-1025. https://doi.org/10.1210/jc.86.3.1020
  7. Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, Villa M, Mannino S, Crosignani P, Bosi E, Luzi L, Ruotolo G, Perseghin G. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011. 34: 210-215. https://doi.org/10.2337/dc10-0665
  8. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF, Poirier P. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008. 28: 1039-1049. https://doi.org/10.1161/ATVBAHA.107.159228
  9. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest. 1997. 100: 1166-1173. https://doi.org/10.1172/JCI119628
  10. Filipovsky J, Ducimetiere P, Safar ME. Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Hypertension. 1992. 20: 333-339. https://doi.org/10.1161/01.HYP.20.3.333
  11. Genelhu VA, Celoria BM, Duarte SF, Cabello PH, Francischetti EA. Not all obese subjects of multiethnic origin are at similar risk for developing hypertension and type 2 diabetes. Eur J Intern Med. 2009. 20: 289-295. https://doi.org/10.1016/j.ejim.2008.09.009
  12. Grundy SM, Barlow CE, Farrell SW, Vega GL, Haskell WL. Cardiorespiratory fitness and metabolic risk. Am J Cardiol. 2012. 109: 988-993. https://doi.org/10.1016/j.amjcard.2011.11.031
  13. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004. 109: 433-438. https://doi.org/10.1161/01.CIR.0000111245.75752.C6
  14. Iacobellis G, Ribaudo MC, Leto G, Zappaterreno A, Vecci E, Di Mario U, Leonetti F. Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. Obes Res. 2002. 10: 767-773. https://doi.org/10.1038/oby.2002.104
  15. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D, Rabasa-Lhoret R. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab. 2005. 90: 4145-4150. https://doi.org/10.1210/jc.2005-0482
  16. Kim YJ, Shin YO. Effects of aerobic exercise on cardiopulmonaryrelated factors in exercise-induced hypertension patients. Korean Society of Exercise Physiology 2007. 16: 131-140.
  17. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991. 114: 345-352. https://doi.org/10.7326/0003-4819-114-5-345
  18. Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 2009. 32: 2297-2299. https://doi.org/10.2337/dc09-0574
  19. Lee KJ. Obesity and Functional Gastrointestinal Disorders. Korean J Gastroenterol. 2012. 59: 1-7. https://doi.org/10.4166/kjg.2012.59.1.1
  20. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, Kim DY, Kwon HS, Kim SR, Lee CB, Oh SJ, Park CY, Yoo HJ. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract. 2007. 75: 72-80. https://doi.org/10.1016/j.diabres.2006.04.013
  21. Lind L, Siegbahn A, Ingelsson E, Sundstrom J, Arnlov J. A detailed cardiovascular characterization of obesity without the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2011. 31: e27-34. https://doi.org/10.1161/ATVBAHA.110.221572
  22. Lynch LA, O'Connell JM, Kwasnik AK, Cawood TJ, O'Farrelly C, O'Shea DB. Are natural killer cells protecting the metabolically healthy obese patient? Obesity (Silver Spring) 2009. 17: 601-605. https://doi.org/10.1038/oby.2008.565
  23. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D'Agostino RB. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006. 91: 2906-2912. https://doi.org/10.1210/jc.2006-0594
  24. Park J, Kim SH, Cho GY, Baik I, Kim NH, Lim HE, Kim EJ, Park CG, Lim SY, Kim YH, Kim H, Lee SK, Shin C. Obesity phenotype and cardiovascular changes. J Hypertens. 2011. 29: 1765-1772. https://doi.org/10.1097/HJH.0b013e32834a50f3
  25. Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V, Sladek R, Rabasa-Lhoret R. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond). 2011. 35: 971-981. https://doi.org/10.1038/ijo.2010.216
  26. Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y, Lee JH. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (Lond). 2006. 30: 1529-1534. https://doi.org/10.1038/sj.ijo.0803304
  27. St-Pierre AC, Cantin B, Mauriege P, Bergeron J, Dagenais GR, Despres JP, Lamarche B. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ. 2005. 172: 1301-1305. https://doi.org/10.1503/cmaj.1040834
  28. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR. The obese without cardio-metabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008. 168: 1617-1624. https://doi.org/10.1001/archinte.168.15.1617
  29. World Health Organization, International Association for the Study of Obesity, International Obesity Task Force, The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: health Communications. 2000.
  30. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008. 117: 1658-1667. https://doi.org/10.1161/CIRCULATIONAHA.107.739714